Searched for
FABRICE EGROS
Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...09 Jul, 2025, 03.32 PM IST- Lupin inks pact with China's Sino Universal Pharmaceuticals for Tiotropium dry powder inhalerLupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler tr...16 Jun, 2025, 12.00 PM IST
- Lupin acquires UK-based firm for 12.3 million poundsLupin has acquired UK-based Renascience Pharma for £12.3 million, enhancing its branded medicine portfolio. The acquisition allows Lupin to...02 Apr, 2025, 09.17 PM IST
- Lupin ties up with Scope Opthalmics to market eyecare products in MexicoDrug maker Lupin has signed a distribution agreement with Ireland-based Scope Ophthalmics to market the Optase range of eye care products i...30 Sep, 2024, 06.45 PM IST
- Lupin inks pact with Celnova Pharma for distribution of drug in 2 South American nationsLupin's subsidiary has signed a pact with Celnova Pharma to distribute NaMuscla in Argentina and Colombia. The drug treats non-dystrophic m...27 Sep, 2024, 09.47 PM IST
- Lupin divests women's health specialty business in US to Evofem Biosciences for nearly $84 mnLupin announced the sale of its US commercial women’s health specialty business, focusing on Solosec, to Evofem Biosciences. Solosec, an FD...15 Jul, 2024, 07.05 PM IST
- Stocks in the news: Linde India, Vedanta, Wipro, Indus Towers and IndiGoLinde India, KSB, Vesuvius India and Money Masters Leasing & Finance are the companies that will announce their earnings for quarter ended ...24 Feb, 2022, 07.52 AM IST
- Lupin inks pact with Shenzhen Foncoo to introduce products in ChinaThe company would continue to explore additional partnership opportunities in China to leverage its global portfolio including complex gene...19 Jan, 2022, 12.10 PM IST
- Lupin divests Kyowa Criticare to Neopharma GroupShares of Lupin closed at Rs 737, up marginally by 0.02 per cent, on Thursday.23 Aug, 2019, 07.47 AM IST
- Exploring ways to establish presence in China as part of APAC region push: LupinThe Mumbai-based firm expects to generate revenues of over USD 100 million from the region, excluding the Japanese market, over the next fe...14 Oct, 2018, 12.44 PM IST
- Lupin aims to be numero uno in biosimilar etanercept in JapanIt takes 12-13 months for the Japanese drug authorities to give product approvals.22 Jun, 2018, 02.09 PM IST
- Buy Lupin Ltd. target Rs 1470.0 : Sumeet BagadiaBuy Lupin Ltd. at a price target of Rs 1470.0 and a stoploss at Rs 1400.0 from entry point21 Apr, 2017, 12.53 PM IST
- Lupin arm in pact to distribute anti-depressant drug in JapanLupin President Dr. Fabrice Egros said the Astellas agreement reinforces Kyowa's transition toward a hybrid pharmaceutical specialty care c...27 Feb, 2017, 12.46 PM IST
- Lupin appoints Thierry Volle as President of EMEA businessDrug major Lupin has appointed Thierry Volle as President of Europe, the Middle-East & Africa (EMEA) with immediate effect based at the com...05 Nov, 2015, 07.46 PM IST
- Lupin appoints Martin Mercer as head of Latin American businessThe Latin American region is a market of strategic focus for the company and one of the fastest growing pharmaceutical markets globally, sh...26 Oct, 2015, 05.04 PM IST
- Lupin appoints Fabrice Egros as President of Asia Pacific businessEgros was with NovaMedica where he was the Deputy CEO/COO and instrumental in setting up an integrated new pharmaceutical business.23 Oct, 2015, 06.37 PM IST
Load More
